Clinical Trials in Atlanta

Showing 4941-4960 of 19,805 trials

Observational Maternal COVID-19 Vaccination Study

NCT04826640

This is a prospective, observational study. During the study, pregnant women will be followed post COVID-19 vaccination. Injection-site (local) and systemic reaction data will be assessed on vaccination day and during the 7 days following the second vaccination using either identical web-based or paper diaries, depending on study participant preference. Maternal serum samples will be collected for antibody titers relevant to COVID-19 at time points that include: prior to vaccination, \~29 days post second vaccination, and at delivery. At Duke University, maternal and infant cord blood will be collected at delivery and analyzed for the same antibody titers. At other clinical sites, these delivery samples will only be collected if feasible. Pregnant women will be followed through 90 days postpartum. with comprehensive obstetric and neonatal outcomes obtained from medical record review.

Pregnancy

Duke University146 participantsStarted May 2021

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Durham, North Carolina, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

NCT05827978

This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.

Seasonal Influenza

ModernaTX, Inc.8,411 participantsStarted Apr 2023

Anniston, Alabama, United States • Athens, Alabama, United States • Cullman, Alabama, United States +100 more locations

Observational Maternal COVID-19 Vaccination Study

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Find Trials by Condition in Atlanta

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

MitraClip EXPAND G4 Study

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

AutoInflammatory Disease Alliance Registry (AIDA)

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors